Debt-to-equity in % of Barinthus Biotherapeutics plc. from Q1 2023 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Barinthus Biotherapeutics plc. quarterly Debt-to-equity history and change rate from Q1 2023 to Q3 2025.
Barinthus Biotherapeutics plc. Debt-to-equity for the quarter ending 30 Sep 2025 was 25.1 %, a 48% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Barinthus Biotherapeutics plc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	25.1	+8.13	+48%	30 Sep 2025
Q2 2025	22.3	+5.47	+32.6%	30 Jun 2025
Q1 2025	20.6	+5.32	+34.8%	31 Mar 2025
Q4 2024	18.9	+4.65	+32.6%	31 Dec 2024
Q3 2024	16.9	+3.62	+27.2%	30 Sep 2024
Q2 2024	16.8	+4.49	+36.5%	30 Jun 2024
Q1 2024	15.3	+3.31	+27.6%	31 Mar 2024
Q4 2023	14.3			31 Dec 2023
Q3 2023	13.3			30 Sep 2023
Q2 2023	12.3			30 Jun 2023
Q1 2023	12			31 Mar 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.